ACI's 8th Annual Summit on Biosimilars

Join Faegre Baker Daniels' Jessica Cox for a discussion assessing the impact of labeling on product liability litigation. Jessica will focus on analyzing the FDA's Draft Guidance on labeling biosimilar products as well as the best practices to market biosimilars to doctors and patients while protecting against liability.